FDA OKs treatment for non-cystic fibrosis bronchiectasis, a chronic lung disease

Return On Information New Jersey

Aug 14, 2025

Insmed Inc., a global biopharmaceutical company, announced this week that the U.S. Food and Drug Administration (FDA) has approved Brinsupri (brensocatib 10 mg and 25 mg tablets),…